VERTEX PHARMACEUTICALS INC shareholders Q1 2022

VERTEX PHARMACEUTICALS INC's ticker is VRTX and the CUSIP is 92532F100. A total of 738 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

VERTEX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 133,000$34,70911.48%
M.D. SASS INVESTORS SERVICES, INC. 146,160$38,1446.53%
GREAT POINT PARTNERS LLC 85,000$22,1825.36%
Eagle Health Investments LP 82,144$21,4375.28%
Sio Capital Management, LLC 58,500$15,2675.05%
MARVIN & PALMER ASSOCIATES INC 42,546$11,1035.00%
Provident Investment Management, Inc. 187,314$48,8834.68%
COLRAIN CAPITAL LLC 10,000$2,6103.64%
BRIDGER MANAGEMENT, LLC 82,800$21,6083.54%
DE BURLO GROUP INC 68,410$17,852,9583.32%
Birch Hill Investment Advisors LLC 234,102$61,0943.26%
Avidity Partners Management LP 545,600$142,3852.96%
Shelter Mutual Insurance Co 43,300$11,3012.96%
China Universal Asset Management Co., Ltd. 32,039$8,3612.96%
Tekla Capital Management LLC 308,884$80,6092.83%
SEAVIEW INVESTMENT MANAGERS LLC 29,030$7,5762.53%
HARDING LOEVNER LP 1,769,276$417,3392.30%
LOOMIS SAYLES & CO L P 6,389,023$1,667,3432.23%
Van Hulzen Asset Management, LLC 77,300$20,1732.14%
F/M Investments LLC 10,076$2,629,5342.12%

External links

This page lists VERTEX PHARMACEUTICALS INC's shareholders in Q1 2022. To view VERTEX PHARMACEUTICALS INC's shareholder history, click here.